Member Info for grouchomarx

There’s no (real) volume yet. Still some people exiting. Talks about an EGM initiative not helping. Works like throwing oil on the fire. Nothing can be disclosed that can’t be disclosed, no matter what meeting. The company is in talks, you either believe that or don’t. I’m positive. And do expect some news on or before 22 november. One more weak of patience at the most.

I’ve got a feeling (nothing more that that) that today is going to be an up day for VAL. Position building for the week of 19 november. Some speculative buying. I can see that.

This board is thinking like https://www.youtube.com/watch?v=R2J5OWdu3xM

There must be news before/on 22-11. You can not face (potential) shareholders telling the same old same old while all investors can clearly see how much marketcap has been destroyed very recently.

Down a shit load. Aren’t we all?

Who told you it went very well? Maybe he/she could tell the market.

Some believe ultimately we all will end up in court. So you could be wright.

No worries in advance mr. Wonka. There’s still time to close deals before any raise of equity. Several months so still time for good things to develop before Christmas. But, first .. Thanksgiving (22-11-2018)! :)

Thinking alike.

So true. And bright side of an ever declining share price is that less to lose in future. :) Not liking the current beating I’m getting but nothing has really changed really. The prospects are still out there all that has changed is the share price. A temporary pain. Just hold on. BOL fellow shareholders!

Thank you for your post. I understand. Something else, having seen the videos and reading RNS's again it's very clear to me VAL is dealing with a consortium. Multiple parties at the same time. It can take more time getting all parties aligned. I think they're going to close a deal. A deal (Morris: "better a bad deal than no deal") will and needs to be closed. I believe the bod knows this.

The share price is 1.5p, obviously this is not priced as a company with guaranteed deals. It’s more or less priced as a failure. We’ve got a research report using conservative numbers that comes up with a NPV of 10p for VAL401 alone. It’s Valirx’s business model to partner/outlicense in early stages. Do you believe them to be in talks about 101, 201, 301 and 401? How likely is it one of them will get a deal shortly? Will the share price be higher than 1.5p when a deal is closed? No matter what you’ve paid for the shares in the past, it all comes down to the question ‘would I buy today for 1.5p’ ? If not, sell. Otherwise hold or add. BOL.

There investments? English is not even my language and I know better than that. Idiots, donkeys? Pot and kettle. Why so offensive and agressive? Never mind.

Cheers Freddie appreciate it! This place can really do with a little less hostility. Investing should be fun, entertaining, challenging and rewarding. We all make mistakes, some (very) costly. Take it up the chin and move on. Learn. Not directed at you Freddie, just a general remark. Lighten up, people!

Don’t know about others but I’m really having trouble following threads on this BB. It’s undoable.

What really is hilarious is that all the people having opinions here state to have “No Opinion”.

I’ve replayed all VAL videos from last year and if there’ll be no VAL401 deal closed I’ll nominate mr. George Morris for the best actor Oscar.

It’s also a lottery because MM’s are allowed to late report trades. Markets are supposed to be transparent, but what we see is not what we get. We’re buying and selling in the Twilight Zone.

I’ve got a strong feeling we’re bottoming here. Nothing is certain though. BOL holders.

Company has stated many times: - to be in licensing discussions with mayor players in the oncology field; -detailed discussions are in progress in respect to a pivotal phase III trial, while external partners will have substantial input in trial design; -commercial activity surrounding VAL401 has continued; -advanced conversations have continued with a number of prospective partners. These statements are facts. You either believe them or not. The business model is outlicensing/partnering. Because of options and shares directors will benefit greatly from any deal closed. Our interests are aligned. I tend to believe negotians are ongoing and it’s priced not accordingly. At this price it’s a calculated risk with a great risk-reward ratio imo.